基于分子对接技术探讨金莲花汤抗新型冠状病毒(2019-nCoV)的潜力 |
投稿时间:2020-03-03 点此下载全文
|
引用本文:赓迪,庞月笙,陶志,王莎,刘晓璇,王如峰.基于分子对接技术探讨金莲花汤抗新型冠状病毒(2019-nCoV)的潜力[J].中国现代中药,2020,22(4):522-532 |
DOI: |
摘要点击次数: 1005 |
全文下载次数: 349 |
|
基金项目:北京市自然基金面上项目(7172129) |
|
中文摘要:目的:对金莲花汤主要成分的抗新型冠状病毒(2019-nCoV或SARS-CoV-2)活性进行虚拟筛选,评价金莲花汤抗2019-nCoV的潜力。方法:采用Autodock软件将金莲花汤中的27种主要成分与2019-nCoV 3CL水解酶(Mpro)进行分子对接。结果:26种化合物可与Mpro蛋白活性中心结合,主要结合成分为黄酮类;主要结合方式为与Mpro蛋白的活性区域形成氢键。结论:金莲花汤表现出Mpro蛋白结合活性,具有抗2019-nCoV的潜力。 |
中文关键词:金莲花汤 新型冠状病毒 3CL水解酶 分子对接 |
|
Investigation on Potential of Jinlianhua Decoction against Novel Coronavirus (2019-nCoV) Based on Molecular Docking |
|
|
Abstract:Objective:To virtually screen the compounds with anti-2019-nCoV activity from the major components of Jinlianhua Decoction,so as to assess the potential of this prescription against 2019-nCoV.Methods:Autodock software was employed to dock 27 major compounds from Jinlianhua decoction with 2019-nCoV 3CL hydrolase (Mpro).Results:Twenty-six compounds,which were mainly flavonoids,out of 27 components tested were docked into the active pocket of Mpro protein primarily though hydrogen bonds.Conclusion:The major compounds of Jinlianhua decoction can bind with Mpro protein and the decoction has a potential against 2019-nCoV. |
keywords:Jinlianhua Decoction 2019-nCoV 3CL hydrolase molecular docking |
查看全文
查看/发表评论 下载PDF阅读器 |